U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07553052) titled 'Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 Counts' on March 31.
Brief Summary: This study aims to evaluate the effect of Vitamin D3 supplementation on inflammatory markers and immune status in patients with HIV who are receiving antiretroviral therapy. Participants will receive Vitamin D3 supplementation for 3 months. Outcomes including Interleukin-6 levels and CD4 counts will be measured to assess the potential benefits of this intervention.
Study Start Date: June 01, 2025
Study Type: INTERVENTIONAL
Condition:
Human Immunodeficiency Virus (HIV)
Intervention:
DRUG: Vitamin D3
Par...